Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Pharmacol Ther. 2018 Mar 22;188:140–154. doi: 10.1016/j.pharmthera.2018.03.004

Figure 1. Potential therapeutic applications for Sirtuin activating compounds (STACs) and Sirtuin inhibiting compounds (STICs).

Figure 1

Chemical structures for examples of activators and inhibitors for Sirt1 and Sirt6 as isoforms with examples for prospective therapeutic applications.